TOPIGEN Pharmaceuticals Inc., a biopharmaceutical company specializing in innovative respiratory therapeutics, today announced that Paul Wotton, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Sachs Associates 5th Annual North American Forum for Investing & Partnering in Biotech & Medtech on March 14, 2006 at 1:55 p.m.
